IMEXPHARM CORPORATIONIMEXPHARM CORPORATIONIMEXPHARM CORPORATION

IMEXPHARM CORPORATION

No trades
See on Supercharts
Market capitalization
‪4.97 T‬VND
‪254.62 B‬VND
‪1.99 T‬VND
‪1.20 M‬
Beta (1Y)
0.62

About IMEXPHARM CORPORATION

CEO
Dao Thi Tran
Headquarters
Cao Lanh
Employees (FY)
‪1.42 K‬
Founded
1977
ISIN
VN000000IMP0
FIGI
BBG000PP6BN0
Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. Its other activities include import and export of medical equipment and instrument; purchasing of materials used for processing its products; wholesale of competent, functional food, drinking water, carbonated water alcohol; and provision of storage services of drugs and medicine raw materials. The company was founded in 1977 and is headquartered in Cao Lanh, Vietnam.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IMP is 69300 VND — it has decreased by 2.39% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HOSE exchange IMEXPHARM CORPORATION stocks are traded under the ticker IMP.
IMEXPHARM CORPORATION is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
IMP stock is 2.45% volatile and has beta coefficient of 0.62. Check out the list of the most volatile stocks — is IMEXPHARM CORPORATION there?
IMEXPHARM CORPORATION revenue for the last quarter amounts to ‪368.00 B‬ VND despite the estimated figure of ‪510.90 B‬ VND. In the next quarter revenue is expected to reach ‪479.00 B‬ VND.
Yes, you can track IMEXPHARM CORPORATION financials in yearly and quarterly reports right on TradingView.
IMP stock has risen by 1.61% compared to the previous week, the month change is a 2.67% rise, over the last year IMEXPHARM CORPORATION has showed a 41.57% increase.
IMP net income for the last quarter is ‪72.35 B‬ VND, while the quarter before that showed ‪59.25 B‬ VND of net income which accounts for 22.11% change. Track more IMEXPHARM CORPORATION financial stats to get the full picture.
Today IMEXPHARM CORPORATION has the market capitalization of ‪4.97 T‬, it has increased by 0.44% over the last week.
Yes, IMP dividends are paid annually. The last dividend per share was ‪1.00 K‬ VND. As of today, Dividend Yield (TTM)% is 1.34%. Tracking IMEXPHARM CORPORATION dividends might help you take more informed decisions.
Like other stocks, IMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMEXPHARM CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
IMP reached its all-time high on Feb 11, 2022 with the price of 82300 VND, and its all-time low was 10000 VND and was reached on Apr 25, 2013.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪1.42 K‬ employees. See our rating of the largest employees — is IMEXPHARM CORPORATION on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMEXPHARM CORPORATION technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMEXPHARM CORPORATION stock shows the strong buy signal. See more of IMEXPHARM CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMEXPHARM CORPORATION EBITDA is ‪463.69 B‬ VND, and current EBITDA margin is 23.25%. See more stats in IMEXPHARM CORPORATION financial statements.